Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study explores the feasibility of SRS/SRT treatment with MLC leaves wider than 2.5 mm at isocenter by inter-comparing treatment plans produced with 2.5, 5.0, and 10.0 mm leaves for various target sizes and shapes. Forty previously treated patients were re-planned using 2.5, 5.0, and 10.0 mm wide MLC leaves. For each patient, all three plans were evaluated and contrasted between them in terms of five metrics: target dose homogeneity, conformity index, organs at risk dose, dose fall off outside the target, and dose to normal tissues. A regularity index RI was introduced that quantified the degree of target shape irregularity. The effect of target size and shape irregularity on feasibility of 5.0 and 10.0 mm leaves was analyzed. Consistent plan degradation was observed for 10.0 mm (sometimes for 5.0 mm) compared to 2.5 mm MLC in terms of the above five plan metrics, but this degradation was small to clinically insignificant. As an exception, when target (PTV) size was smaller than about 1 cm diameter, clinically significant differences were found between 2.5, 5.0, and 10.0 mm MLC. 5.0 and 10.0 mm MLC can be used in SRS/SRT for targets (PTV) diameter larger than 1 cm. For smaller targets, 2.5 mm MLC is clinically superior, 5.0 is acceptable and 10.0 mm MLC is discouraged in terms of PTV dose conformity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693311PMC
http://dx.doi.org/10.3389/fonc.2019.00741DOI Listing

Publication Analysis

Top Keywords

100 mlc
16
mlc leaves
12
0
8
mlc
8
target size
8
size shape
8
100 leaves
8
target dose
8
shape irregularity
8
target
7

Similar Publications

Antibacterial hyaluronic acid hydrogel with sustained release of larazotide as effective colitis treatment.

J Control Release

September 2025

Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou City, Zhejiang Province 325035, China. Electronic address:

Gut barrier loss exacerbated gut microbiota dysbiosis by permitting pathogenic blooms, while gut microbiota dysbiosis caused the development of gut mucosal wounds by reducing mucus and breaking down epithelial tight junction. Current therapies combating colitis often fail to address both gut barrier dysfunction and microbial imbalance. Herein, inspired by natural gut mucus, a dual-crosslinked hydrogel (HSMP-LA) composed of thiol/maleimide-modified hyaluronic acid together with co-loading of antimicrobial ε-polylysine (ε-PL) and larazotide acetate (LA) had been developed as an injectable artificial gut mucus to simultaneously restore barrier integrity and modulate gut microbiota.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a widespread central nervous system degenerative disease in the elderly population. This study aims to uniquely targets this sex-specific vulnerability by investigating the effects of 17β-E2 on the differentiation and migration capabilities of Aβ-damaged NSCs and its potential mechanisms-a critical gap for female-focused AD therapies. Primary NSCs isolated from neonatal SD rats were treated with Aβ25-35 (60 μM) to mimic AD pathology, followed by 17β-E2 (100 nM) with or without BX795 (a Wnt3a/β-catenin inhibitor).

View Article and Find Full Text PDF

Aim: The current planning study sought to assess the potential clinical feasibility and dosimetrics of employing volumetric modulated arc therapy (VMAT) with the HalcyonTM linear accelerator (Linac) using photon optimizer algorithm for total body irradiation (TBI).

Materials And Methods: The upper body and lower body PTVs were optimized independently using a 6 MV FFF beam energy with ten isocenters in the Eclipse treatment planning system (TPS) and photon optimizer algorithm. The treatment plans were delivered using a HalcyonTM E linac (Varian Medical Systems Inc.

View Article and Find Full Text PDF

Background: Access to timely radiotherapy in resource-constrained environments, particularly low- and middle-income countries (LMIC), is hampered by infrastructure constraints, workforce shortages, and a rising cancer burden. Remote radiotherapy planning (treatment planning as a service [TPaaS]) has the potential to enhance workflow efficiency, reduce wait times, and expand access to treatment. However, its integration and feasibility in LMIC public health systems remain underexplored.

View Article and Find Full Text PDF

Nephrogenesis is completed before term birth, but preterm infants continue this process postnatally. It is unknown if preterm neonates are more susceptible to acute kidney injury (AKI) immediately after birth (during nephrogenesis) or later in postnatal development, and if this AKI timing impacts nephron number. Rabbits were exposed to gentamicin (100 mg/kg intraperitoneal) and indomethacin (5 mg/kg orally) on postnatal day (P) 0-3 (early-exposed) or P6-9 (late-exposed).

View Article and Find Full Text PDF